Ceredex Value Advisors LLC Boosts Position in Select Medical Holdings Co. (NYSE:SEM)

Ceredex Value Advisors LLC raised its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 6.7% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 267,150 shares of the health services provider's stock after purchasing an additional 16,800 shares during the period. Ceredex Value Advisors LLC owned 0.21% of Select Medical worth $5,036,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of SEM. Smartleaf Asset Management LLC raised its holdings in Select Medical by 179.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after acquiring an additional 1,473 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Select Medical during the third quarter worth $81,000. Covestor Ltd increased its stake in shares of Select Medical by 33.5% in the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after acquiring an additional 1,244 shares during the last quarter. Virtu Financial LLC purchased a new stake in shares of Select Medical in the third quarter valued at about $210,000. Finally, Tidal Investments LLC purchased a new position in Select Medical during the third quarter worth about $286,000. Hedge funds and other institutional investors own 89.48% of the company's stock.

Select Medical Stock Up 1.7 %

NYSE SEM traded up $0.26 during trading hours on Tuesday, hitting $15.72. 91,902 shares of the company were exchanged, compared to its average volume of 941,748. Select Medical Holdings Co. has a 52-week low of $14.98 and a 52-week high of $40.98. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of 9.52, a PEG ratio of 0.64 and a beta of 1.38. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company has a 50 day moving average of $17.22 and a two-hundred day moving average of $22.70.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The firm had revenue of $1.31 billion during the quarter, compared to analysts' expectations of $1.50 billion. Equities research analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.0625 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.59%. Select Medical's dividend payout ratio (DPR) is presently 15.15%.

Wall Street Analyst Weigh In

A number of research firms recently commented on SEM. Royal Bank of Canada decreased their price objective on Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a report on Monday, February 24th. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research note on Monday, February 24th. Mizuho started coverage on shares of Select Medical in a research report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective for the company. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Finally, UBS Group decreased their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, January 3rd. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Select Medical has a consensus rating of "Moderate Buy" and an average target price of $26.80.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.